Research Updates

Patient & Parent Guides

Guides for patients and parents navigating an inherited retinal disease diagnosis. Clear, compassionate, medically accurate information.

In-depth scientific articles covering specific IRD conditions and genes — including gene therapy breakthroughs, PubMed publication summaries, clinical trial analyses, and detailed condition explainers.

What is this page?

These are in-depth scientific articles covering specific IRD conditions and genes — including gene therapy breakthroughs, PubMed publication summaries, clinical trial analyses, and detailed condition explainers written for patients, families, and researchers.

Looking for the latest headlines? Visit News & Industry Updates for time-sensitive developments from the broader IRD world.

article {condition!== "All"? ` about $ `: ""} {search? ` matching "$ "`: ""}

All articles loaded

Published research and education articles

A 2026 rd10 mouse study found that combining a GALR3-blocking compound with the antioxidant quercetin preserved more photoreceptors and photopic retinal function than either treatment alone. The findings support further research into mutation-independent, multi-target strategies for retinitis pigmentosa.

A 2026 rd10 mouse study found that combining a GALR3-blocking compound with the antioxidant quercetin preserved more photoreceptors and photopic retinal function than either treatment alone. The findings support further research into mutation-independent, multi-target strategies for retinitis pigmentosa.

A 2026 review proposes that mitochondrial DNA released from damaged retinal cells may link oxidative stress, mitochondrial dysfunction, and inflammation in retinitis pigmentosa. Although it has not yet been measured in RP ocular fluids, extracellular mtDNA could become a valuable biomarker for tracking disease activity and testing treatments.

A 2026 review proposes that mitochondrial DNA released from damaged retinal cells may link oxidative stress, mitochondrial dysfunction, and inflammation in retinitis pigmentosa. Although it has not yet been measured in RP ocular fluids, extracellular mtDNA could become a valuable biomarker for tracking disease activity and testing treatments.

A ClinGen expert panel has developed RS1-specific rules to improve how genetic variants linked to X-linked retinoschisis are classified. In a pilot review of 54 variants, the framework updated 21 classifications and could strengthen future research and gene-based therapy development.

A ClinGen expert panel has developed RS1-specific rules to improve how genetic variants linked to X-linked retinoschisis are classified. In a pilot review of 54 variants, the framework updated 21 classifications and could strengthen future research and gene-based therapy development.

A 2026 study found that AI analysis of 2D and 3D facial photographs identified Stickler syndrome with up to 96% accuracy when focusing on the area around the eyes and nose. The approach could help reduce diagnostic delays and bring earlier attention to the condition’s serious retinal-detachment risk.

A 2026 study found that AI analysis of 2D and 3D facial photographs identified Stickler syndrome with up to 96% accuracy when focusing on the area around the eyes and nose. The approach could help reduce diagnostic delays and bring earlier attention to the condition’s serious retinal-detachment risk.

A 2026 natural-history study found that average macular sensitivity in Best vitelliform macular dystrophy changed little over about four years. However, microperimetry detected measurable decline in retinal locations that were normal at baseline, offering a potential outcome measure for future BVMD gene therapy trials.

A 2026 natural-history study found that average macular sensitivity in Best vitelliform macular dystrophy changed little over about four years. However, microperimetry detected measurable decline in retinal locations that were normal at baseline, offering a potential outcome measure for future BVMD gene therapy trials.

A 2026 case report links retinitis pigmentosa with Coats-like retinal leakage, complex neurologic symptoms, and two FLVCR1 variants in a 31-year-old patient. The report highlights the value of integrated genetic, neurologic, and retinal care, while showing reduced lipid exudation after anti-VEGF treatment.

A 2026 case report links retinitis pigmentosa with Coats-like retinal leakage, complex neurologic symptoms, and two FLVCR1 variants in a 31-year-old patient. The report highlights the value of integrated genetic, neurologic, and retinal care, while showing reduced lipid exudation after anti-VEGF treatment.

A new *Nature Communications* study maps the structure of the Kir7.1 potassium channel, which is linked to some forms of Leber congenital amaurosis. The findings provide molecular tools and insights that may support future research into KCNJ13-related retinal disease, while also highlighting Kir7.1’s roles beyond the eye.

A new *Nature Communications* study maps the structure of the Kir7.1 potassium channel, which is linked to some forms of Leber congenital amaurosis. The findings provide molecular tools and insights that may support future research into KCNJ13-related retinal disease, while also highlighting Kir7.1’s roles beyond the eye.

Full-field stimulus threshold testing measures the dimmest full-field flash of light a person can detect, making it valuable when standard vision tests are unreliable. A 2026 review highlights its growing role in LCA research and gene therapy trials, while underscoring the need for standardized testing protocols.

Full-field stimulus threshold testing measures the dimmest full-field flash of light a person can detect, making it valuable when standard vision tests are unreliable. A 2026 review highlights its growing role in LCA research and gene therapy trials, while underscoring the need for standardized testing protocols.

High-resolution adaptive optics imaging has revealed disrupted cone organization in areas of RHO-associated retinitis pigmentosa that appear relatively preserved. The study also found greater rod disruption at the advancing disease edge and highlights cone-based measures as potential tools for future trials designed to preserve photoreceptor structure.

High-resolution adaptive optics imaging has revealed disrupted cone organization in areas of RHO-associated retinitis pigmentosa that appear relatively preserved. The study also found greater rod disruption at the advancing disease edge and highlights cone-based measures as potential tools for future trials designed to preserve photoreceptor structure.

Researchers developed a light-based laboratory test that measures CYP4V2 enzyme activity after delivery of a Bietti crystalline dystrophy gene-therapy vector. The validated assay could support quality control, batch release, and stability testing for future rAAV-hCYP4V2 products.

Researchers developed a light-based laboratory test that measures CYP4V2 enzyme activity after delivery of a Bietti crystalline dystrophy gene-therapy vector. The validated assay could support quality control, batch release, and stability testing for future rAAV-hCYP4V2 products.

A 2026 case report followed two siblings with Alström syndrome who received the SGLT2 inhibitor ertugliflozin for 11 months. Both had improved blood-glucose control, with early improvements in insulin resistance and favorable lipid changes; larger prospective studies are needed to define long-term benefits.

A 2026 case report followed two siblings with Alström syndrome who received the SGLT2 inhibitor ertugliflozin for 11 months. Both had improved blood-glucose control, with early improvements in insulin resistance and favorable lipid changes; larger prospective studies are needed to define long-term benefits.

A 2026 case report describes two brothers diagnosed with both X-linked retinoschisis and X-linked ichthyosis, the first reported coexistence of these conditions. Genetic testing identified an RS1 variant linked to XLRS and an STS-region deletion linked to the boys’ skin symptoms, highlighting the value of comprehensive family evaluation.

A 2026 case report describes two brothers diagnosed with both X-linked retinoschisis and X-linked ichthyosis, the first reported coexistence of these conditions. Genetic testing identified an RS1 variant linked to XLRS and an STS-region deletion linked to the boys’ skin symptoms, highlighting the value of comprehensive family evaluation.

The 2026 AXIS randomised trial found that oral acetazolamide did not meaningfully reduce cystoid fluid collections or improve most visual outcomes in people with X-linked retinoschisis. A modest improvement in retinal sensitivity and possible benefit in a small subset of participants support further research into personalised approaches.

The 2026 AXIS randomised trial found that oral acetazolamide did not meaningfully reduce cystoid fluid collections or improve most visual outcomes in people with X-linked retinoschisis. A modest improvement in retinal sensitivity and possible benefit in a small subset of participants support further research into personalised approaches.

A recent study investigates the rare coexistence of pathogenic mutations in both the BEST1 and EFEMP1 genes, utilizing advanced multimodal imaging to reveal unique structural and functional retinal features.

A recent study investigates the rare coexistence of pathogenic mutations in both the BEST1 and EFEMP1 genes, utilizing advanced multimodal imaging to reveal unique structural and functional retinal features.

A recent 2026 study demonstrates how advanced artificial intelligence models, including ResNet and RETFound, can accurately classify Best disease and other inherited retinal diseases using specialized retinal imaging.

A recent 2026 study demonstrates how advanced artificial intelligence models, including ResNet and RETFound, can accurately classify Best disease and other inherited retinal diseases using specialized retinal imaging.

A recent 2026 study explores the clinical phenotype and genetic mechanisms of PDE6C-associated achromatopsia and progressive cone dysfunction, expanding our understanding of rare retinal variants.

A recent 2026 study explores the clinical phenotype and genetic mechanisms of PDE6C-associated achromatopsia and progressive cone dysfunction, expanding our understanding of rare retinal variants.

A new study has identified three novel variants in the *UBAP1L* gene, linking them to both rod-cone and cone-rod dystrophy. This discovery is crucial for advancing genetic diagnosis and understanding the underlying causes of these inherited retinal diseases, opening new avenues for future gene-specific treatments. The research highlights the importance of comprehensive genetic testing in providing precise diagnoses for patients.

A new study has identified three novel variants in the *UBAP1L* gene, linking them to both rod-cone and cone-rod dystrophy. This discovery is crucial for advancing genetic diagnosis and understanding the underlying causes of these inherited retinal diseases, opening new avenues for future gene-specific treatments. The research highlights the importance of comprehensive genetic testing in providing precise diagnoses for patients.

A recent nationwide Portuguese study provides crucial insights into RPGR-associated retinal dystrophies, revealing diverse clinical presentations and genetic variations. These findings are vital for improving diagnosis, counseling, and readiness for emerging gene-based therapies for conditions like Cone-Rod Dystrophy.

A recent nationwide Portuguese study provides crucial insights into RPGR-associated retinal dystrophies, revealing diverse clinical presentations and genetic variations. These findings are vital for improving diagnosis, counseling, and readiness for emerging gene-based therapies for conditions like Cone-Rod Dystrophy.

A recent publication in *Clinics in Liver Disease* highlights advancements in understanding and treating Alagille Syndrome (ALGS), a genetic disorder causing bile buildup in the liver. The review emphasizes the importance of molecular classification and discusses current and emerging therapies, particularly ileal bile acid transport (IBAT) inhibitors. These inhibitors offer a new, non-invasive approach to managing severe itching and potentially slowing disease progression in ALGS patients.

A recent publication in *Clinics in Liver Disease* highlights advancements in understanding and treating Alagille Syndrome (ALGS), a genetic disorder causing bile buildup in the liver. The review emphasizes the importance of molecular classification and discusses current and emerging therapies, particularly ileal bile acid transport (IBAT) inhibitors. These inhibitors offer a new, non-invasive approach to managing severe itching and potentially slowing disease progression in ALGS patients.

A new study reveals early molecular changes in Gyrate Atrophy, highlighting the retinal pigment epithelium and choroid (RPE/Cho) as a key site of damage even before vision loss is detectable. These findings offer crucial insights into the disease's progression and suggest new avenues for developing more targeted treatments for this inherited retinal disease. The research could lead to better early interventions and refined gene therapy strategies.

A new study reveals early molecular changes in Gyrate Atrophy, highlighting the retinal pigment epithelium and choroid (RPE/Cho) as a key site of damage even before vision loss is detectable. These findings offer crucial insights into the disease's progression and suggest new avenues for developing more targeted treatments for this inherited retinal disease. The research could lead to better early interventions and refined gene therapy strategies.

A new study on optogenetic gene therapy, published in *Bioengineering (Basel, Switzerland)*, shows promise for Stargardt disease. The therapy, using MCO-010 delivered via AAV, improved visual function and retinal electrical responses in a mouse model without affecting retinal thickness. This research offers a hopeful, gene-independent approach for restoring vision in Stargardt patients.

A new study on optogenetic gene therapy, published in *Bioengineering (Basel, Switzerland)*, shows promise for Stargardt disease. The therapy, using MCO-010 delivered via AAV, improved visual function and retinal electrical responses in a mouse model without affecting retinal thickness. This research offers a hopeful, gene-independent approach for restoring vision in Stargardt patients.

A recent study highlights the critical challenge of distinguishing Stargardt disease and other inherited retinal conditions from geographic atrophy (GA), a late stage of age-related macular degeneration. Accurate diagnosis is essential, especially with new GA treatments, to ensure patients receive appropriate care and avoid misdiagnosis. This research emphasizes the need for advanced imaging and genetic testing to differentiate these visually similar conditions.

A recent study highlights the critical challenge of distinguishing Stargardt disease and other inherited retinal conditions from geographic atrophy (GA), a late stage of age-related macular degeneration. Accurate diagnosis is essential, especially with new GA treatments, to ensure patients receive appropriate care and avoid misdiagnosis. This research emphasizes the need for advanced imaging and genetic testing to differentiate these visually similar conditions.

A new study reveals how mutations in the *INPP5E* gene, linked to Joubert Syndrome, disrupt the formation of light-sensing photoreceptors in the eye. Using human retinal organoids, researchers found that INPP5E is crucial for building healthy outer segment membranes, offering new insights for potential treatments.

A new study reveals how mutations in the *INPP5E* gene, linked to Joubert Syndrome, disrupt the formation of light-sensing photoreceptors in the eye. Using human retinal organoids, researchers found that INPP5E is crucial for building healthy outer segment membranes, offering new insights for potential treatments.

A recent case report highlights that Joubert Syndrome can be challenging to diagnose, even in children with normal cognitive function, as symptoms can overlap with autism spectrum disorder. The case underscores the importance of repeat neuroimaging and comprehensive genetic testing when new neurological signs emerge, even if initial tests were normal.

A recent case report highlights that Joubert Syndrome can be challenging to diagnose, even in children with normal cognitive function, as symptoms can overlap with autism spectrum disorder. The case underscores the importance of repeat neuroimaging and comprehensive genetic testing when new neurological signs emerge, even if initial tests were normal.